Sustained Funding, Strong Partnerships Critical To Preventing Drug-Resistant Malaria

Friends of the Global Fight Blog: The Emerging Risk of Drug Resistant Malaria
Maile Young, communications intern at Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, discusses malaria parasitic resistance to artemisinin-based combination therapies (ACTs) in the Greater Mekong Subregion, which “could have potentially devastating consequences for the global fight to eradicate malaria.” She highlights several initiatives aimed at preventing the spread of drug resistant malaria, concluding, “If we continue to build strong partnerships to facilitate the path from funding to treatment to prevention, this newly emerging problem can be stopped” (4/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.